Equitable Trust Co. Has $1.52 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Equitable Trust Co. decreased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.1% during the 4th quarter, Holdings Channel.com reports. The firm owned 2,920 shares of the medical equipment provider’s stock after selling 328 shares during the period. Equitable Trust Co.’s holdings in Intuitive Surgical were worth $1,524,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Berbice Capital Management LLC acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $26,000. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new stake in Intuitive Surgical during the fourth quarter worth approximately $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the third quarter worth approximately $38,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 2.2 %

NASDAQ ISRG opened at $595.70 on Tuesday. The company has a market capitalization of $212.18 billion, a price-to-earnings ratio of 92.93, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a fifty day simple moving average of $554.85 and a 200 day simple moving average of $514.80.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 5,940 shares of company stock worth $3,346,964 over the last three months. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of a number of analyst reports. Piper Sandler reissued an “overweight” rating and set a $670.00 price target (up previously from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. UBS Group increased their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research report on Monday, January 27th. Truist Financial upped their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday, January 24th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Barclays upped their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.